Quick Takeaways
- This page summarizes Robert E. Conway's Form 4 filing for ALPINE IMMUNE SCIENCES, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 04 Jan 2022, 16:31.
Robert E. Conway - 03 Jan 2022 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.
- Role
- Director
- Signature
- /s/ James Paul Rickey, attorney-in-fact
- Issuer symbol
- N/A
- Transactions as of
- 03 Jan 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 04 Jan 2022, 16:31:43 UTC
- Previous filing
- 27 Sep 2021
- Next filing
- 19 Dec 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert E. Conway filed Form 4 for ALPINE IMMUNE SCIENCES, INC. on 04 Jan 2022."
What Changed
- Previous filing in this sequence was filed on 27 Sep 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALPN | Stock Option (Right to buy) | Award | $0 | +10,000 | $0.000000 | 10,000 | 03 Jan 2022 | Common Stock | 10,000 | $13.89 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. |
| F2 | 1/12th of the shares subject to the option become vested and exercisable on February 3, 2022 and 1/12th of the shares subject to the option shall vest monthly thereafter. |